FI952049A0 - Antimikrobiset 5-hydratsino-kinolonijohdannaiset - Google Patents

Antimikrobiset 5-hydratsino-kinolonijohdannaiset

Info

Publication number
FI952049A0
FI952049A0 FI952049A FI952049A FI952049A0 FI 952049 A0 FI952049 A0 FI 952049A0 FI 952049 A FI952049 A FI 952049A FI 952049 A FI952049 A FI 952049A FI 952049 A0 FI952049 A0 FI 952049A0
Authority
FI
Finland
Prior art keywords
hydrazino
antimicrobial
quinolone derivatives
quinolone
derivatives
Prior art date
Application number
FI952049A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952049A (fi
Inventor
Jr Thomas Prosser Demuth
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of FI952049A0 publication Critical patent/FI952049A0/fi
Publication of FI952049A publication Critical patent/FI952049A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI952049A 1992-10-30 1995-04-28 Antimikrobiset 5-hydratsino-kinolonijohdannaiset FI952049A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30
PCT/US1993/010091 WO1994010163A1 (fr) 1992-10-30 1993-10-22 Derives antimicrobiens de 5-hydrazino-quinolone

Publications (2)

Publication Number Publication Date
FI952049A0 true FI952049A0 (fi) 1995-04-28
FI952049A FI952049A (fi) 1995-04-28

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952049A FI952049A (fi) 1992-10-30 1995-04-28 Antimikrobiset 5-hydratsino-kinolonijohdannaiset

Country Status (21)

Country Link
EP (1) EP0666853A1 (fr)
JP (1) JPH08502750A (fr)
KR (1) KR950704301A (fr)
CN (1) CN1064357C (fr)
AU (1) AU687018B2 (fr)
BR (1) BR9307347A (fr)
CA (1) CA2148003A1 (fr)
CZ (1) CZ282581B6 (fr)
EG (1) EG20543A (fr)
FI (1) FI952049A (fr)
HU (1) HUT72072A (fr)
IL (1) IL107323A (fr)
MX (1) MX9306814A (fr)
NO (1) NO951640L (fr)
NZ (1) NZ257470A (fr)
PL (1) PL178094B1 (fr)
RU (1) RU2126000C1 (fr)
SG (1) SG59979A1 (fr)
SK (1) SK54795A3 (fr)
WO (1) WO1994010163A1 (fr)
ZA (1) ZA938089B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
ATE190972T1 (de) * 1994-08-02 2000-04-15 Procter & Gamble Verfahren zur herstellung von antimikrobiellen verbindungen
EP0775145A1 (fr) * 1994-08-02 1997-05-28 The Procter & Gamble Company Procede d'obtention d'antimicrobiens a base de quinolonyle lactame et nouveaux composes intermediaires
CA2242242C (fr) * 1996-02-09 2001-08-07 Toyama Chemical Co., Ltd. Derives de l'acide quinolonecarboxylique et leurs sels
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PT1901749T (pt) * 2005-05-18 2016-11-04 Raptor Pharmaceuticals Inc Fluoroquinolonas aerossolizadas e suas utilizações
EE05697B1 (et) 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained
EA010601B1 (ru) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Производные хинолина в качестве антибактериальных агентов
CN101020647B (zh) * 2007-02-14 2011-03-30 杭州师范学院 一种β-环丙胺基丙烯酸(酯)的合成方法
US8063066B2 (en) 2007-03-19 2011-11-22 Takeda Pharmaceutical Company Limited MAPK/ERK kinase inhibitors
DK3092901T3 (da) * 2007-10-05 2020-05-18 Senhwa Biosciences Inc Quinolonanaloger og fremgangsmåder relateret dertil
MX2010012855A (es) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd Derivados de [4-(1-amino-etil)-ciclohexil]-metil-amina y [6-(1-amino-etil)-tetrahidro-piran-3-il]-metil-amina como antibacterianos.
ES2809177T3 (es) 2008-10-07 2021-03-03 Horizon Orphan Llc Inhalación de levofloxacino para reducir la inflamación pulmonar
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
CA2773033C (fr) 2009-09-04 2016-10-11 Mpex Pharmaceuticals, Inc. Utilisation de levofloxacine en aerosol pour traiter la fibrose kystique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
IE66202B1 (en) * 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
JPH05506033A (ja) * 1990-04-18 1993-09-02 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 抗微生物性キノロニルラクタム類
WO1992009596A1 (fr) * 1990-11-30 1992-06-11 Warner-Lambert Company Stereoisomeres individuels de 7-[3-(aminoalkyl)-1-pyrrolidinyl]-quinolones et de naphtyridones utilises comme agents antibacteriens

Also Published As

Publication number Publication date
MX9306814A (es) 1994-07-29
CA2148003A1 (fr) 1994-05-11
ZA938089B (en) 1994-06-07
SK54795A3 (en) 1995-12-06
BR9307347A (pt) 1999-05-25
HUT72072A (en) 1996-03-28
PL178094B1 (pl) 2000-02-29
NZ257470A (en) 1997-08-22
EG20543A (en) 1999-07-31
KR950704301A (ko) 1995-11-17
NO951640D0 (no) 1995-04-28
AU687018B2 (en) 1998-02-19
SG59979A1 (en) 1999-02-22
IL107323A (en) 2000-06-01
RU95110762A (ru) 1997-01-10
CN1064357C (zh) 2001-04-11
JPH08502750A (ja) 1996-03-26
NO951640L (no) 1995-06-30
IL107323A0 (en) 1994-01-25
WO1994010163A1 (fr) 1994-05-11
FI952049A (fi) 1995-04-28
CN1092773A (zh) 1994-09-28
EP0666853A1 (fr) 1995-08-16
HU9501237D0 (en) 1995-06-28
RU2126000C1 (ru) 1999-02-10
CZ282581B6 (cs) 1997-08-13
CZ109795A3 (en) 1995-12-13
AU5409794A (en) 1994-05-24
PL308671A1 (en) 1995-08-21

Similar Documents

Publication Publication Date Title
ATA75293A (de) Indolderivate
DE69208877D1 (de) Chinuclidinderivate
NO922182L (no) Krystallinske oksatiolan-derivater
DE59309028D1 (de) Viruswirksame desinfektionsmittel
DE59300018D1 (de) Fungizide Azolylmethyl-fluorcycloproplylderivate.
NO924000D0 (no) Antimikrobielle kinolontiourea-forbindelser
NO920103L (no) Antibakterielle midler
DE69330497D1 (de) Chinazolin-derivate
FI925763A (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
KR950700911A (ko) 살균약제로서의 치환된 3-피롤리디닐티오-카르바페넴(Substituted 3-Pyrrolidinylthio-Carbapenems as Antimicrobial Agents)
DE59308714D1 (de) Cyclobutan-benzol-derivate
NO305294B1 (no) R°rhenger
FI952049A (fi) Antimikrobiset 5-hydratsino-kinolonijohdannaiset
ATE172738T1 (de) Substituierte 6-aza-androstenone
FI952804A0 (fi) Substituoidut bentsatsepinonit
NO952288D0 (no) Benzazepinon-derivater
FI925469A (fi) Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
DE69313890D1 (de) 5-Aminoflavon-Derivate
MX9206710A (es) Derivados de piridinol
DE59309389D1 (de) Substituierte Thiophencarbonsäureamide
DE69211197D1 (de) 1-Hydroxyvitamin D-Derivate
NO930739D0 (no) Substituerte fenylkinazolinderivater
KR930702353A (ko) 2- 카르바페넴 유도체
NO932638D0 (no) 21-klor-pregnanderivat
DE59310082D1 (de) Substituierte 2-arylpyrrole